Overall rank by patents
#14,846
of 49,997 tracked assignees
USPTO PatentsView assignee record - 20 granted patents across 34 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).
The verdict
According to USPTO PatentsView, Paris ranks #14,846 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 34 technology areas.
USPTO PatentsView assignee plate
Corpus R14846 · Foreign Corporation #14,846 · 20 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Owl biomedical, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Paris Sciences ET… · this assignee
41 score
3D Lighting… · lowest
7 score
What this shows Paris's Innovation Score is 41.4/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Paris Sciences ET Lettres - Quartier Latin is a focused PatentsView assignee: 34 CPC subclasses with 25% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2021 (6 grants) versus a trough of 2 in 2017. By volume, Paris sits between Owl biomedical, Inc. and PHD, Inc..
Paris Sciences ET Lettres - Quartier Latin shows 2 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Owl biomedical, Inc.
20 patents
Paion UK Limited
20 patents
Palfinger AG
20 patents
PAN Pacific Plastics MFG., Inc.
20 patents
Penthera Partners, Inc.
20 patents
Peugeot Saveurs
20 patents
PF Waterworks LP
20 patents
PHD, Inc.
20 patents
Paris Sciences ET Lettres - Quartier Latin
20 patents
What this shows Paris holds 20 patents at rank #14,840, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #14,840 in granted patent volume.
Other assignees with the most granted patents in Paris's primary technology class.
Paris's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 33% higher than 67% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 10.0% |
| 2018 | 3 | 15.0% |
| 2019 | 3 | 15.0% |
| 2020 | 4 | 20.0% |
| 2021 | 6 | 30.0% |
| 2024 | 2 | 10.0% |
Top 15 of 34 technology areas
Overall rank by patents
#14,846
of 49,997 tracked assignees
41.4 out of 100
What to do with this data
Paris Sciences ET Lettres - Quartier Latin's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.